Correction to: Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.

Qi, Yulan; McKeever, Kathleen; Taylor, Julie; Haller, Christine; Song, Wenjie; Jones, Simon A; Shi, Jack

Qi, Yulan; McKeever, Kathleen; Taylor, Julie; Haller, Christine; Song, Wenjie; Jones, Simon A; Shi, Jack.

Afiliação

Qi Y; Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA, 94949, USA. yulan.qi@gmail.com.
McKeever K; BioMarin Pharmaceutical Inc., 105 Digital Dr., Novato, CA, 94949, USA. yulan.qi@gmail.com.
Taylor J; Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA, 94949, USA.
Haller C; Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA, 94949, USA.
Song W; Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA, 94949, USA.
Jones SA; Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA, 94949, USA.
Shi J; Ascendis Pharmaceutical Inc., 500 Emerson St., Palo Alto, 94301, USA.

Clin Pharmacokinet ; 58(5): 685, 2019 May.

Article em En | MEDLINE | ID: mdl-30515718

ABSTRACT

ABSTRACT

Introduction section, para 3, lines 2-4 which previously read.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google